Terms: = Pancreatic cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
9 results:
1. Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group.
Takaki S; Kurosaki M; Mori N; Tsuji K; Ochi H; Marusawa H; Nakamura S; Tada T; Narita R; Uchida Y; Akahane T; Kondo M; Kusakabe A; Furuta K; Kobashi H; Arai H; Nonogi M; Tamada T; Hasebe C; Ogawa C; Sato T; Tamaki N; Yasui Y; Tsuchiya K; Izumi N
Invest New Drugs; 2023 Apr; 41(2):340-349. PubMed ID: 36995548
[TBL] [Abstract] [Full Text] [Related]
2. Management of clinically relevant postoperative pancreatic fistula-related fluid collections after distal pancreatectomy.
Guarneri G; Guazzarotti G; Pecorelli N; Palumbo D; Palucci M; Provinciali L; Limongi C; Crippa S; Partelli S; De Cobelli F; Falconi M
Surg Endosc; 2023 Jul; 37(7):5623-5634. PubMed ID: 36357548
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.
Gantois D; Guilbaud T; Scemama U; Girard E; Picaud O; Lefevre M; Elgani M; Hamidou Z; Moutardier V; Balandraud P; Chirica M; Barbier L; Fuks D; Birnbaum DJ
Langenbecks Arch Surg; 2022 Feb; 407(1):153-165. PubMed ID: 34373941
[TBL] [Abstract] [Full Text] [Related]
4. Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma.
Gu X; Zhang Q; Wu X; Fan Y; Qian J
World J Surg Oncol; 2021 Apr; 19(1):112. PubMed ID: 33845841
[TBL] [Abstract] [Full Text] [Related]
5. A study of multinucleated giant cells in esophageal cancer.
Wang H; Zhou J; Li J; Geng Y; Meng P; Ma C; Zhu Z; Zhang W; Hong L; Quan Y; Wei J; Huang Q; Zhou Y; Su Z; Zhu X; Chen C; Chen S; Gu J
Clin Immunol; 2021 Jan; 222():108600. PubMed ID: 33197619
[TBL] [Abstract] [Full Text] [Related]
6. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
[TBL] [Abstract] [Full Text] [Related]
7. Socioeconomic differences in selection for liver resection in metastatic colorectal cancer and the impact on survival.
Vallance AE; van der Meulen J; Kuryba A; Braun M; Jayne DG; Hill J; Cameron IC; Walker K
Eur J Surg Oncol; 2018 Oct; 44(10):1588-1594. PubMed ID: 29895508
[TBL] [Abstract] [Full Text] [Related]
8. Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis.
Chan DT; Luk AO; So WY; Kong AP; Chow FC; Ma RC; Lo AW
BMC Endocr Disord; 2016 Feb; 16():12. PubMed ID: 26911576
[TBL] [Abstract] [Full Text] [Related]
9. Role of crosslinking for agonistic CD40 monoclonal antibodies as immune therapy of cancer.
Richman LP; Vonderheide RH
Cancer Immunol Res; 2014 Jan; 2(1):19-26. PubMed ID: 24416732
[TBL] [Abstract] [Full Text] [Related]